| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874562 Nucleic acid encoding developmentally-regulated endothelial cell locus-1 |
| 02/23/1999 | US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/23/1999 | US5874556 Hybrid genes for use in the production of TH -independent cytotoxic T cells |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 02/23/1999 | US5874539 Antibodies to nuclear matrix proteins |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 02/23/1999 | US5874399 Progenitor B cell stimulating factor |
| 02/23/1999 | US5874308 A first member of a specific binding pair and a conjugate comprising a second member of said specific binding pair and an amino acid sequence comprising a substrate binding region derived from a polysaccharidase |
| 02/23/1999 | US5874307 Process for induction culture of cytotoxic T lymphocytes having killing activity against tumor cells |
| 02/23/1999 | US5874306 Culturing human pancreatic endocrine cells in medium containing extracellular matrix from human bladder carcinoma cells |
| 02/23/1999 | US5874305 Androgen-repressed metastatic human prostate cancer cell line |
| 02/23/1999 | US5874304 Humanized green fluorescent protein genes and methods |
| 02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
| 02/23/1999 | US5874301 Embryonic cell populations and methods to isolate such populations |
| 02/23/1999 | US5874299 Transgene coding for human immunoglobulin heavy chain variable regions, d regions, j regions, mu constant region, and gamma constant region where gamma region is closer to mu region than in natural locus |
| 02/23/1999 | US5874288 Bacillus thuringiensis toxins with improved activity |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874269 Prevention of synthesis of specific enzymes in the pathway for ethylene biosynthesis |
| 02/23/1999 | US5874266 Targeted system for removing tumor cells from cell populations |
| 02/23/1999 | US5874265 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
| 02/23/1999 | US5874253 Expression vectors and genetic engineering |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874165 Materials and method for the immobilization of bioactive species onto polymeric subtrates |
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | CA2133345C A method of limiting the survival of genetically engineered microorganisms in their environment |
| 02/23/1999 | CA1340406C Method to isolate clusters of cell subtypes from organs |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007891A1 90 human secreted proteins |
| 02/18/1999 | WO1999007871A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | WO1999007870A1 Methods for genetically modifying t cells |
| 02/18/1999 | WO1999007868A1 Immunologically privileged cells and uses thereof |
| 02/18/1999 | WO1999007866A1 Matrix attachment regions |
| 02/18/1999 | WO1999007865A1 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 02/18/1999 | WO1999007864A1 Materials and methods for controlling homopteran pests |
| 02/18/1999 | WO1999007863A1 Processes for increasing the yield in plants |
| 02/18/1999 | WO1999007859A1 Replication-competent recombinant sabin type 1 strain of poliovirus |
| 02/18/1999 | WO1999007856A1 Novel metalloprotease |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007850A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 02/18/1999 | WO1999007848A1 Mammalian cytokine receptor-11 |
| 02/18/1999 | WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007837A1 Isolation and identification of novel polymerases |
| 02/18/1999 | WO1999007835A2 1-alpha-hydroxylase |
| 02/18/1999 | WO1999007833A1 Method for increasing the efficiency of recombinant aav production |
| 02/18/1999 | WO1999007832A1 Kcnq potassium channels and methods of modulating same |
| 02/18/1999 | WO1999007831A1 Method for the ex-vivo expansion of hematopoietic stem cells |
| 02/18/1999 | WO1999007830A1 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED ARABIDOPSIS THALIANA ENDO-1,4-β-GLUCANASE GENE, PROMOTER AND PROTEIN |
| 02/18/1999 | WO1999007828A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels |
| 02/18/1999 | WO1999007740A2 Lipocalin homologs |
| 02/18/1999 | WO1999007739A2 Dna encoding the human synapsin iii gene and uses thereof |
| 02/18/1999 | WO1999007738A2 Human orphan receptor ntr-1 |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007735A2 Recombinant expression of insulin c-peptide |
| 02/18/1999 | WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6 |
| 02/18/1999 | WO1999007210A1 Genetically engineered duckweed |
| 02/18/1999 | WO1999007208A1 Hypersensitive response elicitor from erwinia amylovora and its use |
| 02/18/1999 | WO1999007207A1 Hypersensitive response elicitor from pseudomonas syringae and its use |
| 02/18/1999 | WO1999007206A1 Hypersensitive response elicitor from erwinia amylovora, its use, and encoding gene |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | CA2639060A1 Transgenic plants of altered morphology and the isolated arabidopsis thaliana endo-1,4-.beta.-glucanase gene, promoter and protein |
| 02/18/1999 | CA2301198A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 02/18/1999 | CA2300985A1 Kcnq potassium channels and methods of modulating same |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2300193A1 Hypersensitive response elicitor from erwinia amylovora, its use, and encoding gene |
| 02/18/1999 | CA2300084A1 Method for increasing the efficiency of recombinant aav production |
| 02/18/1999 | CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/1999 | CA2299619A1 Human orphan receptor ntr-1 |
| 02/18/1999 | CA2299618A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels |
| 02/18/1999 | CA2299617A1 1-a-alpha-hydroxylase materials and methods |
| 02/18/1999 | CA2299605A1 90 human secreted proteins |
| 02/18/1999 | CA2299565A1 Hypersensitive response elicitor from erwinia amylovora and its use |
| 02/18/1999 | CA2299563A1 Hypersensitive response elicitor from pseudomonas syringae and its use |
| 02/18/1999 | CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | CA2299388A1 Processes for increasing the yield in plants |
| 02/18/1999 | CA2299226A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 02/18/1999 | CA2298886A1 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298451A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | CA2298439A1 Lipocalin homologs |
| 02/18/1999 | CA2298068A1 Plants transgenic for a cellulose binding domain with altered morphology |
| 02/18/1999 | CA2298052A1 Matrix attachment regions |